The Market Reports

Synopsis
The global market for Sodium Iodide I-131 Kits and Capsules was estimated to be worth US$ 278 million in 2024 and is forecast to a readjusted size of US$ 637 million by 2031 with a CAGR of 12.8% during the forecast period 2025-2031.
Sodium Iodide I-131 is a radioactive isotope of iodine used for diagnostic imaging and therapeutic nuclear medicine applications, primarily targeting the thyroid gland. It exploits the fact that the thyroid avidly absorbs iodine to deliver precise radioactive treatment or imaging contrast.
Cancer is the second leading cause of death in the world, and its number of deaths and cases is increasing year by year. At the same time, based on the unparalleled advantages of nuclear medicine in precision treatment and integrated tumor diagnosis and treatment, the demand for radionuclide drugs and nuclear medicine examinations is expected to increase year by year. The demand for sodium iodide [131I] capsules and solutions has also increased, mainly including diseases such as thyroid tumors and hyperthyroidism.
Governments in many countries are encouraging and supporting innovation and development in the medical industry, including research on nuclear medicine and radiopharmaceuticals, which provides policy support for the development of the sodium iodide [131I] capsule and solution market.
With the advancement of research and development and production technology of radiopharmaceuticals, more effective and safer sodium iodide [131I] capsules and solutions have been produced, thus promoting the development of the industry.
The use of radiopharmaceuticals is subject to strict regulations and supervision. Failure to comply with regulations may lead to product recalls or market access barriers, thus affecting market development.
The public's understanding of radiopharmaceuticals is insufficient, and some patients may have doubts or concerns about radiotherapy, which may affect the market demand for sodium iodide I-131 drugs.
The safety of radiopharmaceuticals is a key factor in the development of the market, and any safety accidents or leaks may have a negative impact on the industry's image and the market.
With the continuous advancement of science and technology, new production technologies and processes will be introduced into the industry. These new technologies can improve product quality, increase production efficiency, and reduce costs.
Many countries are reforming their healthcare systems to provide better medical services and more effective treatments. This reform is expected to promote the use of sodium iodide [131I] capsules and solutions and bring more opportunities to the industry.
Global cooperation and competition will have an impact on the development of the industry. Cooperation between manufacturers, suppliers, and research institutions in different countries and regions helps promote technological innovation and market expansion, but there is also fierce competition.
This report aims to provide a comprehensive presentation of the global market for Sodium Iodide I-131 Kits and Capsules, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of Sodium Iodide I-131 Kits and Capsules by region & country, by Type, and by Application.
The Sodium Iodide I-131 Kits and Capsules market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Sodium Iodide I-131 Kits and Capsules.
Market Segmentation
By Company
International Isotopes Inc
CNNC
DC Pharma
Curium Pharma
Jubilant Pharmova
PDRadiopharma
ANSTO
POLATOM（NCBJ）
NTP Radioisotopes
Isotope JSC (Rosatom)
Institute of Isotopes Co. Ltd.
JRTR
Segment by Type
Capsule
Solution
Segment by Application
Hyperthyroidism Treatment
Thyroid Cancer Treatment
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia-Pacific
Europe
Germany
France
U.K.
Italy
Netherlands
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Sodium Iodide I-131 Kits and Capsules company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Revenue of Sodium Iodide I-131 Kits and Capsules in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Revenue of Sodium Iodide I-131 Kits and Capsules in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.

Index